News
BRISBANE, Calif.--(BUSINESS WIRE)--Maverick Therapeutics, Inc., a private biopharmaceutical company pioneering conditionally active bispecific T cell targeted immunotherapies, today announced the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback